Guishan Jin

696 total citations
31 papers, 464 citations indexed

About

Guishan Jin is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Guishan Jin has authored 31 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Genetics and 9 papers in Oncology. Recurrent topics in Guishan Jin's work include Virus-based gene therapy research (12 papers), CAR-T cell therapy research (7 papers) and Glioma Diagnosis and Treatment (7 papers). Guishan Jin is often cited by papers focused on Virus-based gene therapy research (12 papers), CAR-T cell therapy research (7 papers) and Glioma Diagnosis and Treatment (7 papers). Guishan Jin collaborates with scholars based in China, Canada and Japan. Guishan Jin's co-authors include Fusheng Liu, Junwen Zhang, Ruifang Mi, Yiqiang Zhou, Gui‐Dong Zhu, Qing Zhang, Shuyu Hao, Sen Cheng, Yunsheng Zhang and Xiaodong Su and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and Brain Research.

In The Last Decade

Guishan Jin

31 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guishan Jin China 12 237 140 120 100 75 31 464
Bhopal Mohapatra United States 14 438 1.8× 174 1.2× 79 0.7× 44 0.4× 69 0.9× 34 691
Christopher Duntsch United States 12 260 1.1× 221 1.6× 113 0.9× 51 0.5× 172 2.3× 13 638
Stefano Marastoni Italy 9 302 1.3× 110 0.8× 113 0.9× 50 0.5× 23 0.3× 14 522
Kathrin A. Schmohl Germany 16 215 0.9× 110 0.8× 75 0.6× 153 1.5× 106 1.4× 25 476
Sarah Hohm United States 7 240 1.0× 182 1.3× 111 0.9× 28 0.3× 171 2.3× 10 571
Gunnhildur Ásta Traustadóttir Iceland 13 281 1.2× 132 0.9× 66 0.6× 79 0.8× 34 0.5× 23 446
Perrine Dahan France 8 400 1.7× 132 0.9× 162 1.4× 25 0.3× 161 2.1× 8 594
Christina Karamboulas Canada 11 566 2.4× 261 1.9× 214 1.8× 74 0.7× 27 0.4× 18 766
Melissa Stafford United States 10 305 1.3× 117 0.8× 100 0.8× 26 0.3× 87 1.2× 11 610

Countries citing papers authored by Guishan Jin

Since Specialization
Citations

This map shows the geographic impact of Guishan Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guishan Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guishan Jin more than expected).

Fields of papers citing papers by Guishan Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guishan Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guishan Jin. The network helps show where Guishan Jin may publish in the future.

Co-authorship network of co-authors of Guishan Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Guishan Jin. A scholar is included among the top collaborators of Guishan Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guishan Jin. Guishan Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Guishan, et al.. (2025). Edaravone dextranol alleviates ferroptosis, Cuproptosis, and blood-brain barrier damage after acute cerebral infarction. Metabolic Brain Disease. 40(3). 134–134. 3 indexed citations
2.
Wang, Jialin, et al.. (2025). Glioblastoma cells secrete ICAM1 via FASN signaling to promote glioma-associated macrophage infiltration. Cellular Signalling. 132. 111823–111823. 1 indexed citations
4.
Su, Xiaodong, Yuan Xie, Junwen Zhang, et al.. (2022). HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis. Cell Death and Disease. 13(10). 861–861. 43 indexed citations
5.
Zhu, Gui‐Dong, Junwen Zhang, Qing Zhang, et al.. (2022). Enhancement of CD70-specific CAR T treatment by IFN-γ released from oHSV-1-infected glioblastoma. Cancer Immunology Immunotherapy. 71(10). 2433–2448. 25 indexed citations
6.
Zhang, Qing, et al.. (2022). Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment. Stem Cell Research & Therapy. 13(1). 284–284. 13 indexed citations
7.
Wang, Jialin, et al.. (2022). P4HA1 Regulates CD31 via COL6A1 in the Transition of Glioblastoma Stem-Like Cells to Tumor Endothelioid Cells. Frontiers in Oncology. 12. 836511–836511. 9 indexed citations
8.
Zhang, Junwen, Jialin Wang, Mingxin Li, et al.. (2022). Oncolytic HSV-1 suppresses cell invasion through downregulating Sp1 in experimental glioblastoma. Cellular Signalling. 103. 110581–110581. 5 indexed citations
9.
Zhang, Junwen, et al.. (2021). P4HA1 Down-Regulation Inhibits Glioma Invasiveness by Promoting M1 Microglia Polarization. OncoTargets and Therapy. Volume 14. 1771–1782. 12 indexed citations
11.
Cheng, Sen, Ruifang Mi, Yu Xu, et al.. (2017). Ferritin heavy chain as a molecular imaging reporter gene in glioma xenografts. Journal of Cancer Research and Clinical Oncology. 143(6). 941–951. 10 indexed citations
12.
Zhou, Yiqiang, Guishan Jin, Ruifang Mi, et al.. (2016). Inhibition of fatty acid synthase suppresses neovascularization via regulating the expression of VEGF-A in glioma. Journal of Cancer Research and Clinical Oncology. 142(12). 2447–2459. 28 indexed citations
13.
Dong, Chengyuan, Ruifang Mi, Guishan Jin, et al.. (2015). Identification of the proliferative effect of Smad2 and 3 in the TGF β2/Smad signaling pathway using RNA interference in a glioma cell line. Molecular Medicine Reports. 12(2). 1824–1828. 10 indexed citations
14.
15.
Zhang, Guobin, Guishan Jin, Ruifang Mi, et al.. (2014). Enhanced Antitumor Efficacy of an Oncolytic Herpes Simplex Virus Expressing an Endostatin–Angiostatin Fusion Gene in Human Glioblastoma Stem Cell Xenografts. PLoS ONE. 9(4). e95872–e95872. 25 indexed citations
16.
Jin, Guishan, Shuyu Hao, Jian Xie, Ruifang Mi, & Fusheng Liu. (2013). Collision tumors of the sella: coexistence of pituitary adenoma and craniopharyngioma in the sellar region. World Journal of Surgical Oncology. 11(1). 178–178. 32 indexed citations
17.
Jin, Guishan, et al.. (2012). VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy. Journal of Cancer Research and Clinical Oncology. 139(3). 475–483. 8 indexed citations
18.
Jin, Guishan, Gui‐Dong Zhu, Zhao Zhi-gang, & Fusheng Liu. (2011). VP22 enhances the expression of glucocerebrosidase in human Gaucher II fibroblast cells mediated by lentiviral vectors. Clinical and Experimental Medicine. 12(3). 135–143. 2 indexed citations
19.
Zhu, Gui‐Dong, Wei Su, Guishan Jin, et al.. (2011). Glioma stem cells targeted by oncolytic virus carrying endostatin–angiostatin fusion gene and the expression of its exogenous gene in vitro. Brain Research. 1390. 59–69. 35 indexed citations
20.
Omori, N., Kazuo Maruyama, Guishan Jin, et al.. (2003). Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin. Neurological Research. 25(3). 275–279. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026